Research validates anti-inflammatory properties of wine using urinary tartaric acid as biomarker

FHS
May 13, 2024
10:02 am

The anti-inflammatory effects of wine by analyzing the relationship between urinary tartaric acid concentrations and changes in serum inflammatory biomarkers.

ALK eyes label expansion after Phase III trial success – Pharmaceutical Technology

ALK plans to seek label expansion to include paediatric patients, with an expected paediatric launch in 2025. Image Credit: Sharomka / Shutterstock. ALK’s Itulatek, a

October 12, 2023

Tennyson On Awakn Life Science’s Application For Phase 3 Trial

[embedded content] In another episode of the The Dales Report Psychedelic Exclusive podcast, we sit down with CEO of Awakn Life Sciences (CBOE: AWKN) Anthony

September 19, 2023

Opinion | ‘Uncertainty’ Is Indeed a Bad Word: A Second Opinion on Pandemic Communication

Olson is a communications expert. In a MedPage Today op-ed earlier this week, the authors made a plea for the government to “communicate about [H5N1]

June 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.